- Oral presentation
- Open Access
Development and validation of 3 Tesla functional cardiac magnetic resonance imaging in preterm and term newborns
© Alan et al; licensee BioMed Central Ltd. 2010
- Published: 21 January 2010
- Cardiac Magnetic Resonance
- Newborn Infant
- Superior Vena Cava
- Cardiac Magnetic Resonance Imaging
- Term Newborn
Circulatory failure causes significant mortality and morbidity in newborn infants. Improvements in clinical circulatory care are limited by the paucity of accurate biomarker outcome measures for clinical trials.
To develop and validate cardiac magnetic resonance (CMR) imaging techniques to assess ventricular function and systemic perfusion in preterm and term newborns, and to compare techniques to existing echocardiographic methods.
All scans were performed with a Philips 3-Tesla MR scanner. Infants were fed and allowed to fall into natural sleep without the use of sedation or anesthesia. Infants were laid in a custom made cradle, with ear protection and routine monitoring. A Flex-M surface receiver coil was placed on the chest wall. No respiratory compensation techniques were used. Acquisition parameters for phase contrast (PC) and balanced fast field echo (bFFE) imaging were optimised. PC assessments of flow were performed immediately distal to the aortic and pulmonary valves, as well as in the superior vena cava (SVC) and descending aorta (DAo). External validation of phase contrast measures was performed with a flow phantom. bFFE sequences were applied for 2 chamber, 4 chamber and short axis views. A short axis stack of 5-7 slices covered the left ventricle from base to apex. Left (LVO) and right (RVO) ventricular output were assessed using CMR Tools processing software. Echocardiographic measurements of LVO were performed within 24 hours of MR imaging.
108 newborn infants with median birth weight 1627 (580-4140) grams, gestation 32 (25-42) weeks were studied. Mean (SD) flow volumes in 28 stable infants were LVO 222 (46), RVO 219 (47), SVC 95 (27) and DAo 126 (32) ml.kg-1.min-1, with flow being higher at lower gestational age. Limits of agreement (LOA) for repeated PC assessment of flow were LVO ± 50.2, RVO ± 55.5, SVC ± 20.9 and DAo ± 26.2 ml.kg-1.min-1. Phase contrast quantification of flow in an external phantom was highly correlated with actual measured flow (r2 = 0.995). Mean (SD) LVO in 75 stable infants by bFFE was 245 (47) ml.kg-1.min-1, LOA for cine assessment of LVO were ± 58.3 ml.kg-1.min-1. LOA for repeated echocardiographic assessment of LVO were ± 108.9 ml.kg-1.min-1.
Detailed CMR assessments of cardiac function and systemic perfusion are feasible in newborn infants, and provide more complete data and with greater accuracy than existing echocardiographic methods.
This article is published under license to BioMed Central Ltd.